vivoPharm Company Profile: Acquisition & Investors

vivoPharm Overview

Founded
2003

Status
Acquired/Merged

Employees
32

Latest Deal Type
M&A

Latest Deal Amount
$9.7M

vivoPharm General Information

Description

Provider of a pre-clinical testing platform intended to offer pharmacology, toxicology and bioanalytical research services to guide drug development. The company's pre-clinical testing platform conducts tailored studies to guide drug development, starting from compound libraries and ending with a comprehensive set of in vitro, in vivo data and reports and also provides all services including toxicology testing and bionalytical analysis to GLP, enabling clients to to get treated in a better way in different disease areas.

Contact Information

Website

www.vivopharm.com.au

Ownership Status

Acquired/Merged
(Operating Subsidiary)

Financing Status

Formerly VC-backed

Primary Industry

Other Pharmaceuticals and Biotechnology

Other Industries

Pharmaceuticals

Parent Company

Vyant Bio

Primary Office

Level 3 Office 29
240 Plenty Road
Bundoora, Victoria 3083
Australia

+61 (03) 0000 0000





Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

vivoPharm Valuation & Funding

Deal Type	Date	Amount	Raised to Date	Post-Val	Status	Stage
4. Merger/Acquisition	15-Aug-2017	$9.7M	00.00	00.00	Completed	Profitable
3. Merger/Acquisition	31-Jan-2016	000.00		000.00	Cancelled	Profitable
2. Corporate	26-Nov-2010	$1.3M	$2.3M		Completed	Profitable
1. Seed Round	06-Feb-2008	$1M	$1M		Completed	Startup

To view vivoPharm’s complete valuation and funding history, request access »

vivoPharm Comparisons

Description

Primary
Industry

HQ Location

Employees

Total Raised

Post Valuation

Last Financing Details

Provider of a pre-clinical testing platform intended to offer pharmacology, toxicology and bioanalytical research servic

Other Pharmaceuticals and Biotechnology

Bundoora, Australia

32 As of 2017

00.00

0.00 0000-00-00

000000&0 00.00

000000

ulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mo

0000 000000000

Princeton, NJ

000 As of 0000

00000

0000 0000-00-00

000000&0 00000

00000000

ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore e

0000 000000000

Freiburg, Germany

000000&0

Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

vivoPharm Competitors (4)

Company Name	Financing Status	Location	Employees	Total Raised	Last Financing Date/Type	Last Financing Amount
Aptuit	Formerly PE-Backed	Princeton, NJ	000	00000	000000&0	00000
000000000	Formerly PE-Backed	Freiburg, Germany			000000&0
00000000000	Corporation	Rockville, MD			000000000 -
000000000 00000000	Private Equity-Backed	Nottingham, United Kingdom	000		0000000 0000

To view vivoPharm’s complete competitors history, request access »

vivoPharm Executive Team (5)

Name	Title	Board Seat	Contact Info
Sabine Brandt	Co-Founder & Executive Finance Manager
Melanie Keller	Division Head, Europe
Chris Holding	Division Head of Efficacy Testing
Joanne Chua Ph.D	Division Head of Toxicology and Pharmacology Australia
Glenn Smits Ph.D	Senior Vice President, Discovery and Early Development

To view vivoPharm’s complete executive team members history, request access »

vivoPharm Board Members (3)

Name	Representing	Role
Brenton Wright	vivoPharm	Board Member
Ian Nisbet Ph.D	vivoPharm	Chairman
Ralf Brandt Ph.D	vivoPharm	Co-Founder, Chief Executive Officer, Board Member & Managing Director